EUVIMEDEUVIMED entdecken
Crossref

Bioinformatic identification of a fatty acid metabolism-related gene signature for prognosis prediction and drug sensitivity assessment in osteosarcoma

Hao Gu, Changsheng Zhang, Yu Li, Chuanzhi Zhang, Xiao Shi, Xinxin Si

Eurasian Journal of Medicine and Oncology · 17.11.2026 · 026310397

DOI: 10.36922/ejmo026310397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 17.11.2026. Verfasst von Hao Gu und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Osteosarcoma is an aggressive malignancy with high metastatic potential, leading to poor prognosis in recurrent and metastatic cases.

Objectives

This study aimed to identify prognostic fatty acid metabolism-related genes (FAMRGs) in osteosarcoma and characterize the clinical and biological features of ACSF2.

Methods

Transcriptomic and clinical data from Therapeutically Applicable Research to Generate Effective Treatments–Osteosarcoma, Genotype-Tissue Expression, and GSE16088 were analyzed. Consistently differentially expressed FAMRGs were screened via dual-cohort validation. Least absolute shrinkage and selection operator and Cox regression analyses were used to select prognostic genes, with overall survival (OS) as the primary endpoint and event-free survival (EFS) as the secondary endpoint. An ACSF2-based prognostic model combined with metastatic status was internally validated by bootstrap resampling. Gene Set Enrichment Analysis, OncoPredict, ESTIMATE, and CIBERSORT analyses were performed to explore ACSF2-associated pathways, drug sensitivity, and immune infiltration. In vitro functional assays were conducted to verify the biological function of acyl-CoA synthetase family member 2 (ACSF2).

Results

Four prognostic FAMRGs were screened from 15 consistently dysregulated genes. Low ACSF2 expression independently predicted inferior OS and EFS, without significant correlation with diagnostic metastasis. The optimized model yielded a corrected C-index of 0.729 and a calibration slope of 0.943. ACSF2 was closely associated with fatty acid and mitochondrial metabolism. The ACSF2-high subgroup showed higher predicted sensitivity to Uprosertib and MN-64 and exhibited distinct immune infiltration patterns. Functional experiments confirmed that elevated ACSF2 expression suppresses the migration and invasion of human osteosarcoma cells.

Conclusion

ACSF2 is a promising candidate prognostic biomarker for osteosarcoma. Its metabolic, pharmacological, and immune correlations are exploratory and require further experimental validation.

Zitieren

APA

Gu, H., Zhang, C., Li, Y., Zhang, C., Shi, X., & Si, X. (2026). Bioinformatic identification of a fatty acid metabolism-related gene signature for prognosis prediction and drug sensitivity assessment in osteosarcoma. Eurasian Journal of Medicine and Oncology, 0(0), 026310397. https://doi.org/10.36922/ejmo026310397

Vancouver

Gu H, Zhang C, Li Y, Zhang C, Shi X, Si X. Bioinformatic identification of a fatty acid metabolism-related gene signature for prognosis prediction and drug sensitivity assessment in osteosarcoma. Eurasian Journal of Medicine and Oncology. 2026;0(0):026310397. doi:10.36922/ejmo026310397

BibTeX
@article{Gu2026,
  author = {Gu, Hao and Zhang, Changsheng and Li, Yu and Zhang, Chuanzhi and Shi, Xiao and Si, Xinxin},
  title = {Bioinformatic identification of a fatty acid metabolism-related gene signature for prognosis prediction and drug sensitivity assessment in osteosarcoma},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026310397},
  doi = {10.36922/ejmo026310397}
}
Kostenlos starten →